Name: Pancreatic Cancer, an Issue of Hematology (en Inglés)
Price: 366.61 PEN
Availability: InStock
Author: Yurgelun Matthew B.,Rubinson Douglas A.
ISBN: 9780323986557

portada Pancreatic Cancer, an Issue of Hematology (en Inglés)

Formato

Libro Físico

Editorial

Elsevier

Autor

Yurgelun Matthew B.,Rubinson Douglas A.

Idioma

Inglés

N° páginas

240

Encuadernación

Tapa Dura

ISBN13

9780323986557

Pancreatic Cancer, an Issue of Hematology (en Inglés)

Yurgelun Matthew B.,Rubinson Douglas A. (Autor) · Elsevier · Tapa Dura

Libro Nuevo

S/ 366,61

S/ 733,22

Ahorras: S/ 366,61

50% descuento

Envío normal

Origen: Reino Unido (Costos de importación incluídos en el precio)

Se enviará desde nuestra bodega entre el Jueves 04 de Julio y el Viernes 19 de Julio.

Lo recibirás en cualquier lugar de Perú entre 2 y 5 días hábiles luego del envío.

Reseña del libro "Pancreatic Cancer, an Issue of Hematology (en Inglés)"

In this issue of Hematology/Oncology Clinics, guest editors Drs. Matthew B. Yurgelun and Douglas A. Rubinson bring their considerable expertise to the topic of Pancreatic Cancer. Top experts in the field cover key topics such as pancreatic adenocarcinoma: trends in epidemiology, risk factors, and outcomes; decision making regarding perioperative therapy in individuals with localized pancreatic adenocarcinoma; the evolving role of radiotherapy in the management of individuals with pancreatic adenocarcinoma; and more. Contains 14 relevant, practice-oriented topics including diabetes, cachexia, sarcopenia, and metabolic factors in individuals with pancreatic adenocarcinoma; PARP inhibitors and other novel therapeutics in pancreatic adenocarcinoma; screening and surveillance for pancreatic adenocarcinoma in high-risk individuals; germline testing for individuals with pancreatic adenocarcinoma and novel genetic risk factors; and more. Provides in-depth clinical reviews on pancreatic cancer, offering actionable insights for clinical practice. Presents the latest information on this timely, focused topic under the leadership of experienced editors in the field. Authors synthesize and distill the latest research and practice guidelines to create clinically significant, topic-based reviews.